Abstract:Summary Background Epileptiform activity is associated with worse patient outcomes, including increased risk of disability and death. However, the effect of epileptiform activity on neurological outcome is confounded by the feedback between treatment with antiseizure medications and epileptiform activity burden. We aimed to quantify the heterogeneous effects of epileptiform activity with an interpretability-centred approach. Methods We did a retrospective, cross-sectional study of patients in the intensive care unit who were admitted to Massachusetts General Hospital (Boston, MA, USA). Participants were aged 18 years or older and had electrographic epileptiform activity identified by a clinical neurophysiologist or epileptologist. The outcome was the dichotomised modified Rankin Scale (mRS) at discharge and the exposure was epileptiform activity burden defined as mean or maximum proportion of time spent with epileptiform activity in 6 h windows in the first 24 h of electroencephalography. We estimated the change in discharge mRS if everyone in the dataset had experienced a specific epileptiform activity burden and were untreated. We combined pharmacological modelling with an interpretable matching method to account for confounding and epileptiform activity–antiseizure medication feedback. The quality of the matched groups was validated by the neurologists. Findings Between Dec 1, 2011, and Oct 14, 2017, 1514 patients were admitted to Massachusetts General Hospital intensive care unit, 995 (66%) of whom were included in the analysis. Compared with patients with a maximum epileptiform activity of 0 to less than 25%, patients with a maximum epileptiform activity burden of 75% or more when untreated had a mean 22·27% (SD 0·92) increased chance of a poor outcome (severe disability or death). Moderate but long-lasting epileptiform activity (mean epileptiform activity burden 2% to <10%) increased the risk of a poor outcome by mean 13·52% (SD 1·93). The effect sizes were heterogeneous depending on preadmission profile—eg, patients with hypoxic-ischaemic encephalopathy or acquired brain injury were more adversely affected compared with patients without these conditions. Interpretation Our results suggest that interventions should put a higher priority on patients with an average epileptiform activity burden 10% or greater, and treatment should be more conservative when maximum epileptiform activity burden is low. Treatment should also be tailored to individual preadmission profiles because the potential for epileptiform activity to cause harm depends on age, medical history, and reason for admission. Funding National Institutes of Health and National Science Foundation.

Financing strategic healthcare facilities: the growing attraction of alternative capital.

Safety and efficacy of rapid withdrawal of antiseizure medications during long-term video-electroencephalogram monitoring in children with drug-resistant epilepsy: A retrospective study

Prevalence, Risk Factors and Prognosis of Seizures After Ischemic Stroke

Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy

Acute Symptomatic Seizure Associated With Chronic Antiseizure Medication Use After Stroke

Antiseizure medications for post‐stroke epilepsy: A real‐world prospective cohort study

[Progresses in studies on pulsatile tinnitus].

Clinical Implications of Various Electroencephalographic Patterns in Post-Stroke Seizures. The Utility of Routine Electroencephalogram

Poststroke Seizure and Epilepsy: A Review of Incidence, Risk Factors, Diagnosis, Pathophysiology, and Pharmacological Therapies

Association Between Different Acute Stroke Therapies and Development of Post Stroke Seizures

Regulation of adaptive immune responses by innate cells expressing NK markers and antigen‐transporting macrophages

Risk of Post-stroke Epilepsy Following Stroke-Associated Acute Symptomatic Seizures

Electroencephalogram findings in 10 patients with post-stroke epilepsy: A retrospective study

Outcomes and Predictors of Seizure Recurrence in Post-Stroke Epilepsy, A Retrospective Hospital-based Study.

Treating Post-stroke Epilepsy in a Patient With Multiple Comorbidities

Effects of epileptiform activity on discharge outcome in critically ill patients in the USA: a retrospective cross-sectional study

Status Epilepticus After Mechanical Thrombectomy: The Role Of Early Eeg Assessment In Stroke Unit, Clinical And Radiological Prognostication

Seizure Cycles under Pharmacotherapy

[The importance of celioscopic examination].

Immediate and long‐term management practices of acute symptomatic seizures and epileptiform abnormalities: A cross‐sectional international survey

Periodic Discharges And Status Epilepticus: A Critical Reappraisal